On August 27, 2026, Schroders PLC bought 428,600 shares of TIGERMED (03347) (H shares) at an average of HKD 40.2586 per share, involving about HKD 17.25 million.
Prior to the acquisition, Schroders PLC's long position in TIGERMED was 8.38 million shares, representing 6.8%; following the acquisition, the holding changed to 8.81 million shares, with the long position ratio rising to 7.15%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.